Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Marie D. Ralff & Wafik S. El-Deiry. (2018) TRAIL pathway targeting therapeutics. Expert Review of Precision Medicine and Drug Development 3:3, pages 197-204.
Read now
Read now
Giovanni Luca Ceresoli & Paolo Andrea Zucali. (2012) Anti-angiogenic therapies for malignant pleural mesothelioma. Expert Opinion on Investigational Drugs 21:6, pages 833-844.
Read now
Read now
Articles from other publishers (22)
Liyuan Wang, Xiaoguang Chen & Chunhong Yan. (2022) Ferroptosis: An emerging therapeutic opportunity for cancer. Genes & Diseases 9:2, pages 334-346.
Crossref
Crossref
David Deng & Khalid Shah. (2020) TRAIL of Hope Meeting Resistance in Cancer. Trends in Cancer 6:12, pages 989-1001.
Crossref
Crossref
Fernanda Antunes, Gustavo J. S. Pereira, Renata F. Saito, Marcus V. Buri, Mara Gagliardi, Claudia Bincoletto, Roger Chammas, Gian Maria Fimia, Mauro Piacentini, Marco Corazzari & Soraya Soubhi Smaili. (2020) Effective Synergy of Sorafenib and Nutrient Shortage in Inducing Melanoma Cell Death through Energy Stress. Cells 9:3, pages 640.
Crossref
Crossref
Vasiliki Galani, Anna Varouktsi, Stamatis S. Papadatos, Antigoni Mitselou, Ioannis Sainis, Stavros Constantopoulos & Yotanna Dalavanga. (2019) The role of apoptosis defects in malignant mesothelioma pathogenesis with an impact on prognosis and treatment. Cancer Chemotherapy and Pharmacology 84:2, pages 241-253.
Crossref
Crossref
Leticia Serrano-Oviedo, Marta Ortega-Muelas, Jesús García-Cano, María Ll. Valero, Francisco J. Cimas, Raquel Pascual-Serra, Diego M. Fernandez-Aroca, Olga Roche, María J. Ruiz-Hidalgo, Borja Belandia, José M. Giménez-Bachs, Antonio S. Salinas & Ricardo Sanchez-Prieto. (2018) Autophagic cell death associated to Sorafenib in renal cell carcinoma is mediated through Akt inhibition in an ERK1/2 independent fashion. PLOS ONE 13:7, pages e0200878.
Crossref
Crossref
Shilan Ding, Min Wang, Song Fang, Huibo Xu, Huiting Fan, Yu Tian, Yadong Zhai, Shan Lu, Xin Qi, Fei Wei, Guibo Sun & Xiaobo Sun. (2018) D-dencichine Regulates Thrombopoiesis by Promoting Megakaryocyte Adhesion, Migration and Proplatelet Formation. Frontiers in Pharmacology 9.
Crossref
Crossref
Brandon Hogstad, Marie-Luise Berres, Rikhia Chakraborty, Jun Tang, Camille Bigenwald, Madhavika Serasinghe, Karen Phaik Har Lim, Howard Lin, Tsz-Kwong Man, Romain Remark, Samantha Baxter, Veronika Kana, Stefan Jordan, Zoi Karoulia, Wing-hong Kwan, Marylene Leboeuf, Elisa Brandt, Helene Salmon, Kenneth McClain, Poulikos Poulikakos, Jerry Chipuk, Willem J.M. Mulder, Carl E. Allen & Miriam Merad. (2018) RAF/MEK/extracellular signal–related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. Journal of Experimental Medicine 215:1, pages 319-336.
Crossref
Crossref
Zhaoxia Zou, Yufang Yin, Jenny Lin, Li-chen J. Hsu, Vanessa L. Brandon, Fan Yang, Richard Jove, Rahul Jandial, Gang Li & Mike Y. Chen. (2016) Convection-enhanced delivery of sorafenib and suppression of tumor progression in a murine model of brain melanoma through the inhibition of signal transducer and activator of transcription 3. Journal of Neurosurgery 124:5, pages 1310-1318.
Crossref
Crossref
Aaron T. Wecksler, Sung Hee Hwang, Jun-Yan Liu, Hiromi I. Wettersten, Christophe Morisseau, Jian Wu, Robert H. Weiss & Bruce D. Hammock. (2014) Biological evaluation of a novel sorafenib analogue, t-CUPM. Cancer Chemotherapy and Pharmacology 75:1, pages 161-171.
Crossref
Crossref
Susann Voigt, Stephan Philipp, Parvin Davarnia, Supandi Winoto-Morbach, Christian Röder, Christoph Arenz, Anna Trauzold, Dieter Kabelitz, Stefan Schütze, Holger Kalthoff & Dieter Adam. (2014) TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. BMC Cancer 14:1.
Crossref
Crossref
Gordan Srkalovic, Mohamad A. Hussein, Antje Hoering, Jeffrey A. Zonder, Leslie L. Popplewell, Harsha Trivedi, Sandy Mazzoni, Rachel Sexton, Robert Z. Orlowski & Bart Barlogie. (2014)
A phase
II
trial of
BAY
43‐9006 (sorafenib) (
NSC
‐724772) in patients with relapsing and resistant multiple myeloma:
SWOG
S0434
. Cancer Medicine 3:5, pages 1275-1283.
Crossref
Crossref
Scott J Dixon, Darpan N Patel, Matthew Welsch, Rachid Skouta, Eric D Lee, Miki Hayano, Ajit G Thomas, Caroline E Gleason, Nicholas P Tatonetti, Barbara S Slusher & Brent R Stockwell. (2014) Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife 3.
Crossref
Crossref
Vladimir Lazar, Nathalie Lassau, Guillaume Meurice, Yohann Loriot, Carol Peña, Christophe Massard, Caroline Robert, Thomas Robert, Marie-Aude Le Berre, Thierry de Baere, Philippe Dessen, Jean-Charles Soria & Jean-Pierre Armand. (2013) Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples. Investigational New Drugs 32:2, pages 312-322.
Crossref
Crossref
Laurence A. Booth, Seyedmehrad Tavallai, Hossein A. Hamed, Nichola Cruickshanks & Paul Dent. (2014) The role of cell signalling in the crosstalk between autophagy and apoptosis. Cellular Signalling 26:3, pages 549-555.
Crossref
Crossref
J Wan, T Liu, L Mei, J Li, K Gong, C Yu & W Li. (2013) Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling. British Journal of Cancer 109:2, pages 342-350.
Crossref
Crossref
Sarah Shirley & Olivier Micheau. (2013) Targeting c-FLIP in cancer. Cancer Letters 332:2, pages 141-150.
Crossref
Crossref
R Wang, L Xia, J Gabrilove, S Waxman & Y Jing. (2012) Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells. Leukemia 27:2, pages 315-324.
Crossref
Crossref
Roberto E Favoni, Antonio Daga, Paolo Malatesta & Tullio Florio. (2012) Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma. British Journal of Pharmacology 166:2, pages 532-553.
Crossref
Crossref
Vibeke Hervik Bull, Krishnaraj Rajalingam & Bernd Thiede. (2012) Sorafenib-Induced Mitochondrial Complex I Inactivation and Cell Death in Human Neuroblastoma Cells. Journal of Proteome Research 11:3, pages 1609-1620.
Crossref
Crossref
Didier Jean, Julien Daubriac, Françoise Le Pimpec-Barthes, Françoise Galateau-Salle & Marie-Claude Jaurand. (2012) Molecular Changes in Mesothelioma With an Impact on Prognosis and Treatment. Archives of Pathology & Laboratory Medicine 136:3, pages 277-293.
Crossref
Crossref
Roberto E. Favoni & Tullio Florio. (2011) Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma. Trends in Pharmacological Sciences 32:8, pages 463-479.
Crossref
Crossref
Ahmad R. Safa & Karen E. Pollok. (2011) Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy. Cancers 3:2, pages 1639-1671.
Crossref
Crossref